Π Π°Π·ΡΠ°Π±ΠΎΡΠΊΠ° ΡΠ΅ΡΡ-ΡΠΈΡΡΠ΅ΠΌΡ ΠΠ€Π Π΄Π»Ρ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΠΊΠ»Π΅Π½Π±ΡΡΠ΅ΡΠΎΠ»Π° Π² ΠΊΠΎΡΠΌΠ°Ρ ΠΈ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΡΡΠ±ΡΡΡΠ°ΡΠ°Ρ
ΠΠΎΠΌΠΈΠΌΠΎ ΡΠ°ΡΠΌΠ°ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΡΡΠ΅ΠΊΡΠ° ΡΡΠΈ Π²Π΅ΡΠ΅ΡΡΠ²Π° ΠΎΠ±Π»Π°Π΄Π°ΡΡ ΠΈ ΡΠΎΠΊΡΠΈΡΠ΅ΡΠΊΠΈΠΌ Π΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ΠΌ, ΠΏΠΎΡΡΠΎΠΌΡ, ΠΏΠΎΡΡΠ΅Π±Π»Π΅Π½ΠΈΠ΅ Π»ΡΠ΄ΡΠΌΠΈ Π² ΠΏΠΈΡΡ ΠΌΡΡΠ° ΠΈ ΡΡΠ±ΠΏΡΠΎΠ΄ΡΠΊΡΠΎΠ² ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ , ΠΏΠΎΠ»ΡΡΠ°Π²ΡΠΈΡ ΡΠ°ΠΊΠΈΠ΅ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ Ρ ΠΊΠΎΡΠΌΠΎΠΌ Π΄Π»Ρ ΡΡΠΈΠΌΡΠ»ΡΡΠΈΠΈ ΡΠΎΡΡΠ°, ΠΌΠΎΠΆΠ΅Ρ Π²ΡΠ·Π²Π°ΡΡ ΠΎΡΡΠ°Π²Π»Π΅Π½ΠΈΠ΅, ΠΏΡΠΎΡΠ²Π»ΡΡΡΠ΅Π΅ΡΡ Π² ΡΠ°ΠΊΠΈΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΏΡΠΈΠ·Π½Π°ΠΊΠ°Ρ , ΠΊΠ°ΠΊ Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎΠ³ΠΎ ΡΠΈΡΠΌΠ°, ΠΌΡΡΠ΅ΡΠ½ΡΠΉ ΡΡΠ΅ΠΌΠΎΡ, Π³ΠΈΠΏΠΎΠΊΠ°Π»ΠΈΠ΅ΠΌΠΈΡ, ΡΠ°Ρ ΠΈΡΠΈΠ»Π°ΠΊΡΠΈΡ, Π³ΠΎΠ»ΠΎΠ²Π½ΡΠ΅ Π±ΠΎΠ»ΠΈ, ΠΌΡΡΠ΅ΡΠ½ΡΠ΅ ΡΠΏΠ°Π·ΠΌΡ, ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠΌΠΌΡΠ½ΠΎΡΠ΅ΡΠΌΠ΅Π½ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ·. ΠΠΎΠ΄ ΡΠ΅Π΄. Π’. ΠΠ³ΠΎ ΠΈ Π. ΠΠ΅Π½Ρ ΠΎΡΡΠ° / ΠΠ΅Ρ. Ρ Π°Π½Π³Π». -Π.: ΠΠΈΡ, 1988.-446 Ρ.
- ΠΠ°ΡΠΊΠΎΠ²ΡΠΊΠΈΠΉ, Π.Π. ΠΠ΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΠ΅ ΡΡΠ΅Π΄ΡΡΠ²Π° / Π. Π ΠΠ°ΡΠΊΠΎΠ²ΡΠΊΠΈΠΉ. 14-Π΅ ΠΈΠ·Π΄. Π’. 1. — Π.: ΠΠΠ «ΠΠ·Π΄Π°ΡΠ΅Π»ΡΡΡΠ²ΠΎ ΠΠΎΠ²Π°Ρ ΠΠΎΠ»Π½Π°», 2001. — Π‘.230−243.
- Π Π°ΠΊΡΠΎΠΏΠ°ΠΌΠΈΠ½: ΠΡΠ΅Π½ΠΊΠ° ΠΎΡΡΠ°ΡΠΎΡΠ½ΡΡ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ² Π½Π΅ΠΊΠΎΡΠΎΡΡΡ Π²Π΅ΡΠ΅ΡΠΈΠ½Π°ΡΠ½ΡΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π² ΠΏΠΈΡΠ΅ / Π‘ΠΎΡΠΎΠΊΠΎΠ²ΠΎΠΉ Π΄ΠΎΠΊΠ»Π°Π΄ ΠΠ±ΡΠ΅Π΄ΠΈΠ½Π΅Π½Π½ΠΎΠ³ΠΎ ΠΊΠΎΠΌΠΈΡΠ΅ΡΠ° ΡΠΊΡΠΏΠ΅ΡΡΠΎΠ² Π€ΠΠ/ΠΠΠ ΠΈΠΎ ΠΏΠΈΡΠ΅Π²ΡΠΌ Π΄ΠΎΠ±Π°Π²ΠΊΠ°ΠΌ. Π‘Π΅ΡΠΈΡ ΡΠ΅Ρ Π½ΠΈΡΠ΅ΡΠΊΠΈΡ Π΄ΠΎΠΊΠ»Π°Π΄ΠΎΠ² ΠΠΠ. 1994. № 832. — Π‘.56−68.
- Π’Π°Π³ΠΈΡΠΎΠ², Π.Π‘. ΠΠΎΡΠΌΠΎΠ½Π°Π»ΡΠ½ΡΠΉ ΡΡΠ°ΡΡΡ Ρ Π±ΡΡΠΊΠΎΠ² Π² ΠΏΠ΅ΡΠ΅Ρ ΠΎΠ΄Π½ΡΠΉ ΠΏΠ΅ΡΠΈΠΎΠ΄ Π²ΡΡΠ°ΡΠΈΠ²Π°Π½ΠΈΡ ΠΈ ΠΏΡΠΈ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠΈ ΠΊΠ»Π΅Π½Π±ΡΡΠ΅ΡΠΎΠ»Π°: ΠΠ²ΡΠΎΡΠ΅Ρ. Π΄ΠΈΡ. ΠΠ°Π½Π΄.Π±ΠΈΠΎΠ».Π½Π°ΡΠΊ: 03.00.13 / Π.Π‘.Π’Π°Π³ΠΈΡΠΎΠ²- ΠΠΎΡΠΎΠ²ΡΠΊ. ΠΠΠΠ ΡΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ, Π±ΠΈΠΎΡ . ΠΈ ΠΏΠΈΡ. Ρ-Ρ ΠΆΠΈΠ²-ΡΡ . ΠΠΎΡΠΎΠ²ΡΠΊ, 1994. — 25 Ρ.
- Π’Π΅ΠΎΡΠΈΡ ΠΈ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ° ΠΈΠΌΠΌΡΠ½ΠΎΡΠ΅ΡΠΌΠ΅Π½ΡΠ½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° / Π. Π’. ΠΠ³ΠΎΡΠΎΠ², Π. Π ΠΡΠΈΠΏΠΎΠ², Π. Π ΠΠ·Π°Π½ΡΠΈΠ΅Π², Π. Π ΠΠ°Π²ΡΠΈΠ»ΠΎΠ²Π°. Π.: ΠΡΡΡ. Π¨ΠΊ., 1991.
- Π’Π΅ΡΠ½ΠΎΠ½ Π. ΠΠΎΠ²ΡΠ΅ ΠΌΠ΅ΡΠΎΠ΄Ρ ΠΈΠΌΠΌΡΠ½ΠΎΠ°Π½Π°Π»ΠΈΠ·Π° / Π’Π΅ΡΠ½ΠΎΠ½ Π., ΠΠ°Π½Π³Ρ Π΅ΠΌ Π. Π ., ΠΠΎΠ»ΠΊΠΎΡΡ Π. Π. // ΠΠ΅Ρ. Ρ Π°Π½Π³Π».- ΠΠΎΠ΄ ΡΠ΅Π΄. Π. Π. ΠΠ³ΠΎΡΠΎΠ²Π°. Π.: ΠΠΈΡ, 1991. — 280 Ρ.
- Π£ΠΊΠ°Π·Π°Π½ΠΈΠ΅ ΠΠ»Π°Π²Π½ΠΎΠ³ΠΎ Π³ΠΎΡΡΠ΄Π°ΡΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ Π²Π΅ΡΠ΅ΡΠΈΠ½Π°ΡΠ½ΠΎΠ³ΠΎ ΠΈΠ½ΡΠΏΠ΅ΠΊΡΠΎΡΠ° ΠΏΠΎ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ ΠΠΎΡΡΠ΄Π°ΡΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ Π²Π΅ΡΠ΅ΡΠΈΠ½Π°ΡΠ½ΠΎΠ³ΠΎ Π½Π°Π΄Π·ΠΎΡΠ° Π·Π° ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ΠΌ Π³ΠΎΡΠΌΠΎΠ½Π°Π»ΡΠ½ΡΡ ΡΡΠΈΠΌΡΠ»ΡΡΠΎΡΠΎΠ² ΡΠΎΡΡΠ° ΠΈ ΡΠΈΡΠ΅ΠΎΡΡΠ°ΡΠΈΠΊΠΎΠ² Π² ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠΈ ΠΆΠΈΠ²ΠΎΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΠΈΡΡ ΠΎΠΆΠ΄Π΅Π½ΠΈΡ № 13−7-1/900 ΠΎΡ 04.10.99 Π³.
- Adam, A. Detection of clenbuterol residues in hair / Adam A., Gervais N., Panoyan A. // The Analyst. 1994. — Vol.119. — P.2663−2666.
- Ansari, A.A. ELISA solid phase: stability and binding characteristics / Ansari A.A., Ilattikudur N.S., Joshi S.R., Medeira M.A. // J. Immunol. Meth. 1985. -Vol.84.-P. 117−124.
- Avrameas, S. Enzyme Immunoassays and related techniques: Development and limitations / Immunochemistry. 1969. — V.6 — P.43−52.
- Baker, P.K. Phenylethanolamine derivatives and acid addition salts thereof for enhancing the growth rater of meat-producing animals and improving the efficiency of feed utilization thereby / Baker P.K., Kiernan J.A. // U.S. Patent 4,404,222. -1983.
- Bosh, A.M.G. Specificity, sensitivity and reproductibility of enzyme immunoassays. In: Enzyme labeled immunoassay of hormones and drugs / Bosh A.M.G., Van Hell H., Brands J. et al // S.B.Pal, ed., Water de Gruyter. Berlin. -1978. — P. 175−187.
- Boyd, D. Matrix solid phase dispersion linked to solid phase extraction for beta agonists in liver samples: An update / Boyd D., O’Keeffe M., Smyth M.R. // Analytical Proceedings. 1995. — Vol.32. — P.301−303.
- Boyd, D. Matrix solid phase dispersion linked to immunoassay techniques for the determination of clenbuterol in bovine liver samples / Boyd D., Shearan P., IIopkins J.P. et al. // Anal. Proc. 1993. — Vol.30. — P. 156−157.
- Boyd, D. Application of matrix solid-phase dispersion for the determination of clenbuterol in liver samples / Boyd D., Shearan P., Hopkins J.P. et.al. // Analytics Chimica Acta. 1993. — Vol.275. — P.221−226.
- Boyd, D. Methods for the determination of p-agonists in biological matrices / Boyd D, O’Keeffe M., Smyth M.R. // The Analyst. 1996. — Vol.121. — P.1R-10R.
- Boyd, D. Matrix solid phase dispersion (MSPD) as a multiresidue extraction technique for P-agonists in bovine liver tissue / Boyd D., O’Keeffe M., Smyth M.R. // Analyst. 1994. — Vol. 119. — P. 1467−1470.
- Cantarero, L.A. The adsorptive characteristics of protein for polystyrene and their significance in solid phase immunoassays / Cantarero L.A., Butler J.E., Osborne J. W. // Anal.Biochem. 1980. — Vol. 105. — P.375−382.
- Collins, S. Multi-residue analysis for P-agonists in urine and liver samples using mixed phase columns with determination by radioimmunoassay / Collins S., O’Keeffe M., Smyth M.R. // The Analyst. 1994. — Vol.119. -P.2671−2674.
- Courtheyn, D. Multiresidue enzyme immunoassays for screening beta-agonists in faeces and feeds / Courtheyn D., Bakeroot V., de Voider F. et al. // Food Agric. Immunol. 1994. — Vol.6. — P. 131 -139.
- Cristino, A. Control of the illegal use of clenbuterol in bovine production / Cristino A., Ramos F., da Silveira M.I.N. // Journal of Pharmaceutical and Biomedical Analysis. 2003. — Vol.32. — P.311 -316.
- Degand, G. Determination of clenbuterol in bovine tissues and urine by enzyme immunoassay / Degand G., Bemes-Duyckaerts A., Maghuin-Rogister G. // Journal of Agricultural and Food Chemistry. 1992. — Vol.40. — P.70.
- Dcgroodt, J.M. Immunoaffinity chromatography purification of salbutamol in liver and HPLC-fluorometric detection atrace residue level / Degroodt J.M., Wyhowski-de-Bukanski B., Srebrnik S. // Z. Lebensm. Unters. Forsch. 1992. -Vol.195.-P.566−568.
- Delahaut, Ph. Development of a specific radioimmunoassay for the detection of clcnbuterol residues in treated cattle / Delahaut Ph., Dubois M., Pri-Bar I. et al. // Food Additives and Contaminants. 1991. — Vol.8. — P.43−53.
- Detection of clenbuterol residues in bovine liver, muscle, retina and urine using gas chromatography/mass spectrometry / Blanchflower W.J., Hewit S.A., Cannavan A., et al. // Biol. Mass Spectrom. 1993. — Vol.22. — P.326−330.
- Determination of beta agonists in tissue / Canadian Food Inspection Agency. Centre for Veterinary Drug Residues. Health of Animals Laboratory. 2000. -Version BAGS-SP01. — 13p.
- Dutch consumer orgahisation, Consumentengids, February. 1995. — P. 104 107.
- Dutch consumer organisation, Consumentengids, June. 1993. — P.348−352.
- Elliott, C.T. Observations on the effects of long-term withdrawal on carcass composition and residue concentrations in clenbuterol-medicated cattle / Elliott C.T., Crooks S.R.H., McEvoy J.D.G. et al. // Vet. Res. Commun. 1993. — Vol.17. -P.459−468.
- Elliott, C.T. Effective laboratory monitoring for the abuse of the beta-agonist clenbuterol in cattle / Elliott C.T., Mc Evoy J.D.G., McCaughey W.J. and Shortt II.D. // The Analyst. 1993. — Vol.118. — P.447−448.
- Elliott, C.T. Improved detection of the P-agonists clenbuterol by analysis of retina extracts / Elliott C.T., McEvoy J.D.G., McCaughey W.J., Crooks S.R.H. and I lewitt S.A. // Veterinary record. 1993. — Vol. 132. — P.301 -392.
- Engvall, E. Enzyme-linked immunosorbent assay (ELISA). Quantitatie assay for immunoglobulin G / Engvall E., Perlmann P. // Immunochem. 1971. — Vol.8 -P.871−874.
- Engvall, E. Enzyme-linked immunosorbent assay, ELISA.III. Quantitation of specific antibodies by enzyme-linked antiimmunoglobulin in antigen-coated tubes / Engvall E., Perlmann P. // J. Immunol. 1972. — Vol. 109. — P. 129−135.
- Food poisoning following consumption of clenbuterol-treated veal in Italy / Brambilla G., Loizzo A., Fontana M. et al. // Journal American Med. Assoc. 1997. — Vol.278.-P.635.
- Gaillard, Y. Detection of illegal clenbuterol use in calves using hair analysis / Gaillard Y., Balland A., Doucet F. et al // Application in meat quality control. Journal of Chromatography B. 1997. — Vol.703. — P.85−95.
- Gleixner, A. Einmalapplikation, Mehrfachapplikation und Metabolitenmuster von Clenbuterol beim Menschen / Gleixner A., Sauerwein H., and Meyer H.H.D. // Archiv fUr Lebensmittelhygiene. 1996. — Vol.47. — P. 131 -135.
- Haasnoot, W. A fast immunoassay for the screening of p-agonists in hair / I Iaasnoot W., Stouten P., Schilt R. et al // Analyst. 1998. — Vol. 123. — P.2707−2710.
- Haasnoot, W. Fast clenbuterol residue analysis in urine by HPLC with on-line automated sample processing using immunoaffinity chromatography / Haasnoot W., Ploum M.E., Paulussen R.J. A et al. // Journal of Chromatography. 1990. — Vol.519. -P.323.
- Hahnau, S. Evaluation of commercially available ELISA test kits for the detection of clenbuterol and other P-agonists / Hahnau S., Julicher B. // Food additives and contaminants. 1996. — Vol.13. — P.259−274.
- Harry, J. Mersmann. Overview of the effects of p-adrenergic receptor agonists on animal growth including mechanisms of action / American Society of Animal Science. 1998. — Vol.76. — P. 160−172.
- Hawkins, D.R. The disposition of the combination product 14C-NAB 365 CL/trimethoprim/suIphadiazine in dairy cows / Hawkins D.R., Elsom L.F., de-Salis
- C.M. et al // Unpublished report No. HRC/BOI 111/84680A from Huntingdon Research Centre. Submitted to WHO by Boehringer Ingelheim Vetmedica GmbH, Ingelheim am Rhein, Germany. 1985.
- Hernandez-Carrasquilla, M. Gas chromatography-mass spectrometry analysis of ?-agonists compounds in bovine hair: evaluation of hair extraction procedures // Analytica Chimica Acta. 2001. — Vol.434. — P.59−66.
- Hernandez-Carrasquilla, M. Gas chromatography-mass spectrometry analysis of ?2-agonists in bovine retina // Analytica Chimica Acta. 2000. — Vol.408. -P.285−290.
- Hernandez-Carrasquilla, M. External contamination of bovine hair with ?2-agonists compounds: evaluation of decontamination strategies // Journal of Chromatography. 2002. — Vol.767. — P.325−243.
- Howard, C.B. The effect of surface charge on non-specific binding of rabbit immunoglobulin G in solid-phase immunoassays.// Journal of Immunological Methods 1988. — Vol. 111. — P. 157−166.
- Intoxicacion por Clenbuterol. Datos clinicos y analiticos en un brote en Mostoles / Bilbao-Garay J., Hoyo-Jimenez J.F., Lopez-Jimenez M. et.al. // Rev. Clin. Esp.- 1997.- Vol.197. -P.92−95.
- Jimenez-Carmona, M.M. Ion-pair/supercritical fluid extraction of clenbuterol from samples / Jimenez-Carmona M.M., Tena M.T. // Journal of Chromatography. -1995.-Vol.711.-P.269−276.
- Kopitar, Z. Pharmacokinetic investigations with 14C.-N-AB 365 CL in rats. / Unpublished report No. U69−0109. Submitted to WHO by Boehringer Ingelheim Vetmedica GmbH, Ingelheim am Rhein, Germany. 1970.
- Kopitar, Z. Pharmakokinetik und Metabolitenmuster von Clenbuterol bei der Ratte / Kopitar Z., Zimmer A. // Arzneim. Forsch. Drug Res. — 1976. — Vol.26. -P.1435−1441.
- Kuiper, H.A. Illegal use of ?-adrenergic agonists / Kuiper H.A., Noordam M.Y., van Dooren-Flipsen M.M.H. et al. // European Community. Journal of Animal Science. 1998. — Vol.76. — P. 195−207.
- Meyer, H.H.D. The pharmacokinetics and residues of clenbuterol in veal calves / Meyer H.H.D., Rinke L.M. // Journal of Animal Science. 1991. — Vol.69. -P.4538−4544.
- Mitchell, G.A. Illegal use of ?-adrenergic agonists in the United States / Mitchell G.A., Dunnavan G. // Journal of Animal Science. 1998. — Vol.76. — P.208−211.
- Monroe, D. Enzyme Immunoassay. / Anal. Chem. 1984. — Vol.56. — P.921A-931 A.
- Morgan, D.J. Clinical pharmacokinetics of ?-agonists. Clin. Pharm. 1990. -Vol.18. -P.270−294.
- O’Keeffe, M.J. Supercritical fluid extraction (SFE) as a multi-residue extraction procedure for P-agonists in bovine liver tissue / O’Keeffe M.J., O’Keeffe M. and Glennon J.D. // The Analyst. 1999. — Vol. 124. — P. 1355.
- O’Keeffe, M. J Supercritical fluid extraction of veterinary drug residues from meat / O’Keeffe M.J., O’Keeffe M. // The National Food Centre. Research report No. 19. -Dublin.- 1999. 18p.
- Ostrowski, J.M. Mutagenesis of the (32-adrenergic receptor: How structure elucidates function / Ostrowski J.M., Kjelsberg A., Caron M.G. and Lefkowitz R.J. / Annu. Rev. Pharmacol. Toxicol. 1992. — Vol.32. — P. 167−183.
- Polettini, A. Determination of p2-agonists in hair by gas chromatography/mass spectrometry / Polettini A., Montagna M., Segura J. // Journal Mass Spectrom. -1996.- Vol.31. -P.47−54.
- Polettini, A. Clenbuterol and beta-adrcnergic drugs detected in hair of treated animal by ELISA / Polettini A., Segura J., Gonzalez G. et al. // Clin. Chem. 1995. -Vol.41.-P.945−946.
- Rang, H. P Adrenergic transmission / Rang 11.P., Dale M.M. // Pharmacology, Churchill Livingstone. Edinburgh. — 1987. — P.6−176.
- Rubenstein, K.E. «Homogeneous» enzyme immunoassay / Rubenstein K.E., Schneider R.S. et al // New Immunochemical technique, Biochem., Biophes. Res. Commun. 1972. — Vol.81. — P.846−851.
- Ruffolo, R.R. Chirality in a- and 0- adrenoceptor agonists and antagonists // Tetrahedron. 1991. — Vol.47. — P.9953−9980.
- Salbutamol radioimmunoassay: synthesis and properties of the benzylic succinate of salbutamol / Beaulieu N., Charette C., Loo J.C.K., et al. // Journal of Pharmaceutical and Biomedical Analysis. 1985. — Vol.3. — P.575−579.
- Sauer, M.J. Determination of clenbuterol residues in bovine liver, urine and eye be enzyme immunoassay / Sauer M.J., Pickett R.J.H., MacKenzie A.L. // Anal. Chim. Acta. 1993. — Vol.275. — P. 195−203.
- Schmid, J. Plasma levels and residue analysis in cows and calves / Unpublished report No. U90−0092. Submitted to WHO by Boehringer Ingelheim Vetmedica GmbH, Ingelheim am Rhein, Germany. 1990.
- Schmid, J. CL in the cows milk after oral and intramuscular administration / Unpublished report No. U90−0099. Submitted to WHO by Boehringer Ingelheim Vetmedica GmbH, Ingelheim am Rhein, Germany. 1990.
- Schmid, J. Biotransformation of clenbuterol / Schmid J., Prox A., Zimmer Z. et al. // Fresenius J. Anal. Chem. 1990. — Vol.337. — P. 121.
- Screening and confirmatory method for the determination of 3-agonists in retina with GC-MSD. / EU Reference Laboratory for Residues of Veterinary Drugs. -2000. Version 2. — 24p.
- Shelver, W. Evaluation of commercial immunoassays for cross-reactivity to clenbuterol stereoisomers and bovine metabolites / Shelver W., Smith J.D. // Food Additives and Contaminants. 2000. — Vol.17. — P.837−845.
- Shepherd, M.J. Analysis of Veterinary Drug Residues in Edible Animal Products / Shepherd M.J., C.S. Creaser and R. Purchase. / Food Contaminants. Sources and Surveillance, The Royal Society of Chemistry, Cambridge. 1991. -P. 176.
- Simultaneous determination of Zilpaterol and other-agonists in calf eye by gas chromatography/tandem mass spectrometry / Bocca B., Fiori M., Cartoni C. et al. // Journal of AOAC International. 2003. — Vol.86. — P.8−14.
- Smith, D.J. Distribution, Elimination, and Residues of 14C. Clenbuterol HCL in Holstein Calves / Smith D.J., and Paulson G.D. // Journal of Animal Science. -1997.- Vol.75. -P.454−461.
- Stoffel, B. Effects of the (^-adrenergic agonist clenbuterol in cows: lipid metabolism, milk production, pharmacokinetics and residues / Stoffel B., Meyer H.H.D. // Journal of Animal Science. 1993. — Vol.71. — P. 1875−1881.
- Urbanek, R. Use of the enzyme linked immunosorbent assay for measurement of specific antibodies / Urbanek R., Kemeny D.M., Samuel D. // J. Immunol. Meth. -1985.-Vol.79.-P. 123−131.
- Van Ginkel, L.A. New Trends in Veal Calf Production / Van Ginkel L.A., Stephany R.W., van Rossum I I.J. // In: (by ed. J.II.M. Metz and C.M. Groenestein). EAAP publication. 1991. — Vol.52. — P. 192−197.
- Sawaya, W. N. Screening for p-agonists in sheep urine and eyes by an enzyme-linked immunosorbent assay in the state of Kuwait / Sawaya W.N., Lone K., Husain A. // Food Control 2000. — Vol. 11. — P. 1 -5.
- Wood, W.G. Polystyrene coated with poly (phenylalanine/lysine) and chemically activated with glutaraldehyde / Wood W.G., Gadow A. // J. Clin. Chem. Biochem. 1983. — Vol.21. — P.789−797.
- Yalow, R.S. Assay of plasma insulin in human subjects by immunological methods / Yalow R.S., Berson S.A. // Nature. 1959. — Vol. 184. — P. 1648−1649.
- Yamamoto, I. Enzyme immunoassay for clenbuterol, a p2-adrenergic stimulant / Yamamoto I., Iwata K. //Journal of Immunoassay. 1982.-Vol.3 — P. 155−171.
- Yang, Y.T. Multiple action of-adrenergic agonists on skeletal muscle and adipose tissue / Yang Y.T., McElligott M.A. // Biochem. J. 1989. — Vol.261. — P. l-10.
- Zalko, D. Metabolic fate of clenbuterol in calves / Zalko D., Bories G. and Tulliez J. // Journal Agnc. Food Chemistry. 1998. — Vol.46. — P. 1935−1943.
- Zalko, D. Proceedings of the EuroResidue III Conference on Residues of Veterinary Drugs in Food / Zalko D., Debrauwer L. and Tulliez J. (by ed. N. Haagsma and A. Ruiter). Veldhoven, The Netherlands. — 1996. — P.367−371.
- Zalko, D. Comparative Metabolism of Clenbuterol by Rat and Bovine Liver Microsomes and Slices / Zalko D., Perdu-Durand E., Debrauwer L. et al. // Drug Metabolism and Disposition. 1998. — Vol.26. — P.28−35.
- Zalko, D. Evidence for a New and Major Metabolic Pathway of Clenbuterol Involving in Vivo Formation of an N-IIydroxyarylamine / Zalko D., Debrauwer L., Bones G. and Tulliez J. // Chcm. Res. Toxicol. 1997. -Vol. 10. — P. 197−204.
- Zimmer, A. Einmalapplikation, Mehrfachapplikation und Metabolitenmuster von Clenbuterol beim Menschen // Arzneim. Forsch./Drug Res. — 1976. — Vol.26. -P. 1446−14 550.
- Zimmer, A. Pharmakokinetik und Metabolitenmuster von Clenbuterol beim Kaninchen und bein Hund // Arzneim. Forsch./Drug Res. — 1976. — Vol.26. -P. 1442−1445.